Sarcoidosis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Key Companies – Johnson and Johnson, United Therapeutics, Novartis

May 29 10:31 2023
Sarcoidosis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Key Companies - Johnson and Johnson, United Therapeutics, Novartis
DelveInsight Business Research LLP
DelveInsight’s “Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sarcoidosis, historical and forecasted epidemiology as well as the Sarcoidosis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Sarcoidosis Overview

Sarcoidosis is a multisystem granulomatous inflammatory disease, with lungs and intrathoracic lymph nodes being the most frequently affected sites. Patients typically experience fatigue, weakness, and dyspnea. Furthermore, respiratory muscle weakness, secondary to granulomatous inflammation, is associated with dyspnea and decreased quality of life (QoL).

Sarcoidosis Epidemiology Facts and Insights:

  • The total 7MM prevalent cases of sarcoidosis in 2020 were 249,250, out of which the highest number of cases were observed in the United States. The EU4 countries accounted for 85,602 cases, whereas Japan had 8,921 cases in 2020.

  • In 2020, there were 154,727 prevalent cases of sarcoidosis in the United States.

  • In the United States, Sarcoidosis cases were higher in females than males. In 2020 there were 64,985 males and 89,742 females affected with sarcoidosis. 

  • Among EU4 countries, Germany had the highest number of prevalent cases of Sarcoidosis (29,708 cases) in 2020. 

Click here to learn more about Sarcoidosis Market Landscape

The Report Covers the Sarcoidosis Epidemiology Segmented by –

  • Sarcoidosis prevalent cases 

  • Sarcoidosis gender-specific cases 

  • Sarcoidosis age-specific cases 

Sarcoidosis Market Outlook 

The Sarcoidosis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Sarcoidosis market trends by analyzing the impact of current Sarcoidosis therapies on the market, unmet needs, drivers and barriers, and demand for better technology. It also covers the Sarcoidosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. According to DelveInsight, the Sarcoidosis market in 7MM is expected to witness a major change in the study period 2019-2032.

 Key Companies in the Sarcoidosis Market Include:

  • aTyrPharmaceuticals

  • Johnson and Johnson 

  • United Therapeutics

  • Novartis 

And many more 

Sarcoidosis Therapies Covered in the Report Include:

  • ATYR1923

  • Uptravi

  • Tyvaso

  • CMK 389

And many others 

Learn more about the Key Companies and the Emerging Therapies in the Sarcoidosis Market

Table of Contents 

  1. Key Insights 

  2. Report Introduction 

  3. Executive Summary of Sarcoidosis  

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Sarcoidosis Emerging Therapies

  7. Sarcoidosis Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Click here to read more about the report’s offerings @ Sarcoidosis Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services